Aspira Pathlab — 360° view

Aspira Pathlab, a company in the Healthcare Service Provider industry, reported revenue of ₹6.26 crore and a net loss of ₹1.16 crore for the September 2026 quarter.

Aspira Pathlab (BSE: ASPIRA) closed at ₹131.00 on 20 Nov 2026, up 95.7% over the past year. Its market capitalisation is ₹135 crore.

Share price
₹131.00 (20 Nov 2026)
Market cap
₹135 Cr (20 Nov 2026)
Revenue
₹6 Cr (September 2026 quarter)
Net profit
₹-1 Cr (September 2026 quarter)
ROCE
2.84% (FY26)
ROE
0.69% (FY26)
Book value
₹10.7 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹149.99 / ₹49.00 (20 Nov 2026)
1-year return
95.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: ASPIRA

Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.